Evidence-based guidelines for cardiovascular disease prevention in women
L Mosca, LJ Appel, EJ Benjamin, K Berra… - Circulation, 2004 - Am Heart Assoc
In the wake of the reports of the Women's Health Initiative and the Heart and
Estrogen/Progestin Replacement Study (HERS), which unexpectedly showed that …
Estrogen/Progestin Replacement Study (HERS), which unexpectedly showed that …
2017 cardiovascular and stroke endpoint definitions for clinical trials
This publication describes uniform definitions for cardiovascular and stroke outcomes
developed by the Standardized Data Collection for Cardiovascular Trials Initiative and the …
developed by the Standardized Data Collection for Cardiovascular Trials Initiative and the …
AHA/ACCF Scientific statement on the evaluation of syncope: from the American heart association councils on clinical cardiology, cardiovascular nursing …
SA Strickberger, DW Benson, I Biaggioni, DJ Callans… - Circulation, 2006 - Am Heart Assoc
Conclusions… 324 Syncope, a transient loss of consciousness, is a common clinical
problem. The most common causes of syncope are cardiovascular in origin and are …
problem. The most common causes of syncope are cardiovascular in origin and are …
[HTML][HTML] Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct
RG Nogueira, AP Jadhav, DC Haussen… - … England Journal of …, 2018 - Mass Medical Soc
Background The effect of endovascular thrombectomy that is performed more than 6 hours
after the onset of ischemic stroke is uncertain. Patients with a clinical deficit that is …
after the onset of ischemic stroke is uncertain. Patients with a clinical deficit that is …
[HTML][HTML] Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis
MI Chimowitz, MJ Lynn, H Howlett-Smith… - … England Journal of …, 2005 - Mass Medical Soc
Background Atherosclerotic intracranial arterial stenosis is an important cause of stroke.
Warfarin is commonly used in preference to aspirin for this disorder, but these therapies …
Warfarin is commonly used in preference to aspirin for this disorder, but these therapies …
Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis
SE Kasner, MI Chimowitz, MJ Lynn, H Howlett-Smith… - Circulation, 2006 - Am Heart Assoc
Background—Antithrombotic therapy for intracranial arterial stenosis was recently evaluated
in the Warfarin versus Aspirin for Symptomatic Intracranial Disease (WASID) trial. A …
in the Warfarin versus Aspirin for Symptomatic Intracranial Disease (WASID) trial. A …
Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience
IL Katzan, AJ Furlan, LE Lloyd, JI Frank, DL Harper… - Jama, 2000 - jamanetwork.com
ContextLittle is known regarding outcomes after intravenous tissue-type plasminogen
activator (IV tPA) therapy for acute ischemic stroke outside a trial setting. ObjectiveTo assess …
activator (IV tPA) therapy for acute ischemic stroke outside a trial setting. ObjectiveTo assess …
The warfarin-aspirin symptomatic intracranial disease study
MI Chimowitz, J Kokkinos, J Strong, MB Brown… - Neurology, 1995 - AAN Enterprises
We conducted a retrospective, multicenter study to compare the efficacy of warfarin with
aspirin for the prevention of major vascular events (ischemic stroke, myocardial infarction, or …
aspirin for the prevention of major vascular events (ischemic stroke, myocardial infarction, or …
Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke: the PROACT II trial
CS Kase, AJ Furlan, LR Wechsler, RT Higashida… - Neurology, 2001 - AAN Enterprises
Objective: To analyze the frequency, clinical characteristics, and predictors of symptomatic
intracerebral hemorrhage (ICH) after intraarterial (IA) thrombolysis with recombinant pro …
intracerebral hemorrhage (ICH) after intraarterial (IA) thrombolysis with recombinant pro …
Cooling for acute ischemic brain damage (COOL AID) An open pilot study of induced hypothermia in acute ischemic stroke
DW Krieger, MA De Georgia, A Abou-Chebl… - Stroke, 2001 - Am Heart Assoc
Background and Purpose—Hypothermia is effective in improving outcome in experimental
models of brain infarction. We studied the feasibility and safety of hypothermia in patients …
models of brain infarction. We studied the feasibility and safety of hypothermia in patients …